We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals

By LabMedica International staff writers
Posted on 02 Feb 2026

Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care. More...

However, many laboratory teams lack the structured training needed to translate these data into actionable insights. Until now, no program had offered a comprehensive overview of how data science can be applied in the clinical laboratory. To address this gap, the Association for Diagnostics & Laboratory Medicine (ADLM) has launched its Data Science in Laboratory Medicine Certificate Program.

ADLM’s Data Science in Laboratory Medicine Certificate Program is designed to help clinical laboratory professionals and pathologists use healthcare data to solve challenging patient problems. Through curated real-world examples, participants learn core data science concepts and practical tools to improve testing algorithms, reduce errors, enhance laboratory operation efficiency, and collaborate more effectively with local data analysts. 

Developed by a team of ADLM’s data science experts, the program provides a foundational overview of key data analytics approaches and how they are applied in laboratory medicine and pathology to strengthen professional expertise and clinical impact. The program covers best practices related to data science, ranging from healthcare data security to mitigation of lab data problems, in addition to the use of machine learning in laboratory workflows.

"We are thrilled to launch this new certificate program for laboratory medicine professionals and pathologists who want to stay ahead of the emerging developments in data science," said ADLM President Dr. Paul J. Jannetto. "Our members saw the need for a professional program that would not only address foundational data science education, but that would also raise awareness of the value of data analytics in laboratory medicine. Healthcare professionals who complete this program will be uniquely distinguished in a field increasingly driven by data and analytics."

Related Links
Association for Diagnostics & Laboratory Medicine (ADLM)


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.